AURORA CANNABIS INC (ACB)
Sector: Medicinal Chemicals & Botanical Products
Industry: Drug Manufacturers - Specialty & Generic
Aurora Cannabis Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 5.10 | 5.24 | 5.08 | 5.24 | 2,087,937 |
| Nov 5, 2026 | 5.20 | 5.30 | 5.05 | 5.19 | 5,130,951 |
| Nov 4, 2026 | 5.16 | 5.26 | 5.10 | 5.24 | 3,182,560 |
| Nov 3, 2026 | 4.71 | 5.20 | 4.71 | 5.16 | 9,011,563 |
| Nov 2, 2026 | 4.16 | 4.34 | 4.09 | 4.22 | 2,040,424 |
| Oct 30, 2026 | 4.03 | 4.09 | 3.98 | 4.06 | 807,143 |
| Oct 29, 2026 | 4.05 | 4.14 | 4.04 | 4.08 | 509,991 |
| Oct 28, 2026 | 4.09 | 4.10 | 3.98 | 4.08 | 555,462 |
| Oct 27, 2026 | 3.90 | 4.16 | 3.90 | 4.15 | 579,159 |
| Oct 26, 2026 | 3.85 | 3.95 | 3.84 | 3.90 | 494,669 |
| Oct 23, 2026 | 3.96 | 3.96 | 3.87 | 3.88 | 602,877 |
| Oct 22, 2026 | 3.93 | 4.06 | 3.90 | 3.97 | 683,401 |
| Oct 21, 2026 | 3.98 | 4.09 | 3.92 | 3.96 | 821,301 |
| Oct 20, 2026 | 3.90 | 4.06 | 3.90 | 3.97 | 654,309 |
| Oct 19, 2026 | 4.00 | 4.09 | 3.96 | 3.96 | 617,773 |
| Oct 16, 2026 | 4.11 | 4.12 | 3.98 | 3.99 | 995,324 |
| Oct 15, 2026 | 4.15 | 4.23 | 4.08 | 4.10 | 891,671 |
| Oct 14, 2026 | 4.21 | 4.31 | 4.13 | 4.17 | 1,194,274 |
| Oct 13, 2026 | 4.25 | 4.34 | 4.24 | 4.29 | 650,203 |
| Oct 12, 2026 | 4.51 | 4.55 | 4.29 | 4.35 | 603,943 |
| Name | Shares | % | Source |
|---|---|---|---|
GOLDMAN SACHS GROUP INC | 1.4M | 2.2% | 13F |
Tidal Investments LLC | 1.3M | 2.0% | 13F |
RENAISSANCE TECHNOLOGIES LLC | 785.0K | 1.3% | 13F |
NATIONAL BANK OF CANADA /FI/ | 241.1K | 0.4% | 13F |
MORGAN STANLEY | 240.7K | 0.4% | 13F |
UBS Group AG | 177.6K | 0.3% | 13F |
AdvisorShares Investments LLC | 171.1K | 0.3% | 13F |
Sculptor Capital LP | 103.7K | 0.2% | 13F |
TD ASSET MANAGEMENT INC | 94.7K | 0.2% | 13F |
CITIGROUP INC | 79.0K | 0.1% | 13F |
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers.
The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach.
Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC.
The company's main corporate office is located in Edmonton, Canada.
based on 61.94M shares outstanding
CA30d Avg
1.61M
60d Avg
1.35M
90d Avg
1.40M